**Core tip:** It is not known whether postoperative complications after liver transplant (LT) are associated with poorer long-term survival. The objective of the present study is therefore to analyse the possible influence of postoperative complications on the long-term survival of LT patients. A retrospective study of 164 LT patients was conducted, analysing complications and grading them by means of the Clavien classification and the comprehensive complication index (CCI). We found that a complicated postoperative period -- well-defined by means of the CCI score -- can influence not only short-term survival, but also long-term survival.

INTRODUCTION
============

Liver transplant (LT) is performed in the end stage of a chronic liver disease or acute liver failure. In spite of medical progress --skills and technology- LT is a complex procedure associated with many potential complications, such as bleeding, portal or arterial thrombosis, primary liver dysfunction or biliary leaks or stenosis\[[@B1]-[@B4]\]. Many complications require interventional procedures, reoperations, prolonged intensive care unit and hospital stays and some lead to death.

Several studies have investigated the possible influence of these postoperative complications on the long-term survival of patients treated because of gastric cancer\[[@B5],[@B6]\], colo-rectal cancer\[[@B7]\], colo-rectal liver metastases\[[@B8]\], or squamous cell esophageal carcinoma\[[@B9]\]. However, there are no data concerning LT with the exception of papers dealing with graft damage after biliary or ischemic complications\[[@B10]\].

Postoperative complications were graded using the Dindo-Clavien classification\[[@B11]\], which comprises seven grades based on the therapy required to treat each complication. However, this score does not combine multiple complications in the same patient. The comprehensive complication index (CCI)\[[@B12]\] further develops the Dindo-Clavien classification, taking into account all complications to provide each patient with a combined morbidity score.

The objective of the present study is therefore to analyse the possible influence of postoperative complications on the long-term survival of LT patients.

MATERIALS AND METHODS
=====================

Study design: Retrospective study in a tertiary university hospital in Santander (Spain). The participants were all the patients who received a LT from January 2012 to July 2019. All were adults (*n* = 164) and received a cadaveric transplant following donor brain death -153- or cardiac death -11-. A technique of cava preservation with piggy-back anastomosis was performed in every case. Follow-up was done in the hospital until the end of the study or death.

Demographic, clinical, surgical and pathological variables were recorded from hospital data bases.

Comorbidity was calculated using the Charlson index\[[@B13]\]. The risk after transplantation was calculated by means of the balance of risk (BAR) score\[[@B14]\], which includes donor age, recipient age, model for end-stage liver disease (MELD) score, retransplantation, pretransplant life support and cold ischemia time.

Postoperative complications were graded according to the Clavien-Dindo classification\[[@B11]\] -which grades the most severe complication -and the CCI\[[@B12]\], which calculates the sum of all the complications that are weighted for their severity. CCI was calculated according to the formula available at <https://www.>[assessurgery.com/about_cci-calculator/](assessurgery.com/about_cci-calculator/), with a score between 0 --no complications- and 100 --death-.

Statistical analysis
--------------------

The programme IBM SPSS Statistics version 21.0 (Chicago, EE. UU., 2012) was used. Values of *P* \< 0.05 were considered significant. The Kolmogorov--Smirnov test was used to assess the distribution of the continuous variables. To assess the CCI cut-off value with greatest prognostic accuracy a receiver operating characteristic (ROC) curve was built, with calculation of the area under the curve (AUC). The highest Youden index (sensitivity + specificity -1) was calculated.

For survival analysis, patients who died in the postoperative period before discharge from hospital were excluded. Overall survival was estimated according to the Kaplan-Meier test and distribution comparison with the log-rank test. Groups were compared with the Mann-Whitney test.

To investigate whether other factors such as Charlson comorbidity index, BAR score or hepatocellular carcinoma also influenced survival, a multivariable analysis using the Cox regression was performed. The statistical review of the study was performed by a biomedical statistician.

RESULTS
=======

One hundred and sixty-four patients, 130 men (79.3%) and 34 women (20.7%) with a mean age of 55.3 years (SD = 9.5) were analysed. The most frequent indications for transplant were hepatocellular carcinoma (36%) and alcoholic liver disease (26.7%).

The main variables of donor and recipient are shown in Table [1](#T1){ref-type="table"}.

###### 

Donor and recipient features

  Recipient variables           
  ----------------------------- ----------------
  Gender, *n* (%)               
  Men                           130 (79.3)
  Women                         34 (20.7)
  Child                         
  A                             60 (36.8)
  B                             65 (39.9)
  C                             38 (23.3)
  Indication, *n* (%)           
  OH                            43 (26.7)
  HPC                           58 (36)
  VHC                           13 (8.1)
  Retransplantation             13 (8.1)
  Other                         34 (20.7)
  Age, mean ± SD                55.34 ± 9.55
  BMI, mean ± SD                26.34 ± 4.27
  Charlson index, mean ± SD     5.96 ± 2.06
  MELD, mean ± SD               15.45 ± 6.93
  BAR score, mean ± SD          6.14 ± 3.73
  CCI score, mean ± SD          42.43 ± 25.01
  Donor variables, mean ± SD    
  Age                           61.59 ± 16.02
  Cold ischemia (min)           327.03 ± 119.2
  Donor type                    
  Brain death                   93.3%
  Cardiac death                 6.7%
  Death cause cerebrovascular   80%
  Trauma                        12.7%
  Other                         7.3%

HPC: Hematopoietic progenitor cell; VHC: Venous hematocrit; BMI: Body mass index; MELD: Model for end-stage liver disease; BAR: Balance of risk; CCI: Comprehensive complication index.

All donors were cadaveric, 153 from brain death and 11 from controlled cardiac death (Maastricht type III), with premortem cannulation and normothermic regional perfusion using extracorporeal membrane oxygenation.

Thirteen patients died in hospital (7.9%): 4 due to primary liver dysfunction, 4 due to biliary complications, 3 because of portal thrombosis and 2 because of arterial bleeding.

The most frequent complications (Table [2](#T2){ref-type="table"}) were biliary leaks -23.2%-, biliary strictures --9.1%-, wound infection -13.4%- and hepatic artery thrombosis -10.4%-. The treatment consisted of re-transplantation in 6 patients (3.6%) due to ischemic cholangiopathy -2-, hepatic artery thrombosis -2-, hyperacute rejection -1- and portal thrombosis -1-.

###### 

Postoperative complications and 5-yr survival, *n* (%)

  **Complications**                  **5-yr Survival**   **Log rank**   
  --------------------- ------------ ------------------- -------------- -------
  Acute rejection       Yes          10 (6.1)            55.1           0.857
  No                    154 (93.3)   55.8                               
  Arterial thrombosis   Yes          17 (10.4)           48.3           0.057
  No                    147 (89.6)   56.5                               
  Portal thrombosis     Yes          15 (9.1)            51.1           0.722
  No                    149 (90.9)   54.5                               
  Biliary stricture     Yes          15 (9.1)            54.7           0.898
  No                    149 (90.9)   55.7                               
  Biliary leak          Yes          38 (23.2)           55.4           0.574
  No                    126 (76.8)   56.9                               
  Wound infection       Yes          22 (13.4)           55.3           0.568
  No                    142 (86.6)   58.8                               
  Acute renal failure   No           89 (54.3)           58             0.237
  AKIN I                40 (24.4)    52.1                               
  AKIN II               18 (11)      53.2                               
  AKIN III              17 (10.4)    53.1                               
  Death                 Yes          13 (7.9)                           
  No                    151 (92.1)                                      

The patients were graded according to the Dindo-Clavien classification considering the most severe complications (Table [3](#T3){ref-type="table"}).

###### 

Number of complications according to Clavien classification

  **Clavien**                          **Number**   **Description (*n*)**
  ------------------------------------ ------------ -------------------------------
  0                                    9 (5.5)      
  I                                    4 (2.4)      Surgical wound hematoma (3)
  Postoperative ileus (1)                           
  II                                   73 (44.5)    Portal thrombosis (5)
  Vena cava thrombosis (1)                          
  Intraabdominal hematoma (6)                       
  Intraabdominal abscess (2)                        
  Biliary leak (4)                                  
  Surgical wound infection (7)                      
  Bacteriemia (2)                                   
  Respiratory complication (8)                      
  Acute renal failure (19)                          
  Urinary tract infection (4)                       
  Acute rejection (3)                               
  Thrombocytopenia (1)                              
  Neurological alteration (5)                       
  Fever without a source (5)                        
  Hypocalcemia (1)                                  
  IIIa                                 22 (13.4)    Intraabdominal abscess (3)
  Biliary leak (12)                                 
  Biliary stricture (6)                             
  Perforated diverticulitis (1)                     
  IIIb                                 26 (15.9)    Arterial thrombosis (7)
  Portal thrombosis (2)                             
  Biliary leak (6)                                  
  Biliary stricture (1)                             
  Hemoperitoneum (7)                                
  Vena cava leak (1)                                
  Abdominal hernia (1)                              
  Abdominal compartment syndrome (1)                
  IVa                                  16 (9.8)     Arterial thrombosis (4)
  Portal thrombosis (1)                             
  Biliary leak (1)                                  
  Hemoperitoneum (7)                                
  Vena cava leak (2)                                
  Primary graft dysfunction (1)                     
  IVb                                  1 (0.6)      Primary graft dysfunction (1)
  V                                    13 (7.9)     Arterial thrombosis (4)
  Portal thrombosis (2)                             
  Hemoperitoneum (4)                                
  Ischemic cholangiopathy (1)                       
  Biliary stricture (1)                             
  Bilateral pneumonia (1)                           
  Total                                164 (100)    

Hepatic artery thrombosis happened in 17 patients and was treated as follows: Surgical revascularization in 8, anticoagulation or antiaggregation in 7 and retransplantation in the 2 above-mentioned cases. Portal thrombosis happened in 15 patients and was treated with anticoagulation in 14 and in one by the above-mentioned retransplantation. All patients with biliary leaks or strictures were initially treated by means of endoscopically-placed stents, although one later needed hepatico-jejunostomy.

The mean value of CCI was 4243 (SD = 2501).

Fourteen patients died during follow-up. The causes were: 3 septic complications not directly related with the transplant, 4 biliary complications, 1 bleed due to hepatic artery pseudoaneurism, 2 due to spread of hepatocellular carcinoma, 2 cases of humoral rejection, 1 necrotizing pancreatitis and one death of unknown etiology.

Survival analysis
-----------------

The mean follow-up time of the cohort was 37.76 (SD = 24.5) mo. A ROC curve of CCI with 5-year survival was built. The AUC was 0.826 (0.730-0.922), *P* \< 0.001. The cut-off was calculated by means of the Youden index with a result of 35.95. The sensitivity was 84.6% and the specificity 61.3% (Figure [1](#F1){ref-type="fig"}, Table [4](#T4){ref-type="table"}).

![Comprehensive complication index receiver operating characteristic curve and 5-yr survival. CCI: Comprehensive complication index.](WJGS-26-336-g001){#F1}

###### 

Five-year survival according to comprehensive complication index, *n* (%)

  **CCI**   **5-yr Survival (mo)**   **Log-rank**   
  --------- ------------------------ -------------- ----------
  \< 20.9   12 (7.3)                 60.0           0.167
  ≥ 20.9    152 (92.7)               50.7           
  \< 33.5   78 (47.6)                57.4           \< 0.001
  ≥ 33.5    86 (52.4)                45.7           
  \< 36     88 (53.7)                57.6           \< 0.001
  ≥ 36      76 (46.3)                43.9           

CCI: Comprehensive complication index.

Survival curves for comparison of patients with CCI scores \< 36 *vs* ≥ 36 were calculated. The estimated 5-year survival was 57.65 and 43.95 months, respectively (*P* \< 0.001) (Figure [2A](#F2){ref-type="fig"}).

![Five-year survival between patients with comprehensive complication indexs. A: Comprehensive complication index (CCI) \< 36 *vs* CCI ≥ 36 (*P* \< 0.001); B: CCI \< 33.5 *vs* CCI ≥ 33.5 (*P* \< 0.001); C: CCI \< 20.9 *vs* CCI ≥ 20.9 (*P* = 0.147). CCI: Comprehensive complication index.](WJGS-26-336-g002){#F2}

Other cut-off values were analysed. Comparison between patients with CCI \< 33.5 *vs* \> 33.5 (33.5 = median CCI value) showed estimated 5-year survival was 57.4 and 45.71 mo, respectively (*P* \< 0.0001) (Figure [2B](#F2){ref-type="fig"}). Comparison between patients with CCI \< 20.9 *vs* \> 20.9 (20.9 = mode CCI value) showed estimated 5-year survival was 60 and 57 months, respectively (*P* = 0.147) (Figure [2C](#F2){ref-type="fig"}).

The univariate analysis did not show any association between individual complications and long-term survival (Table [2](#T2){ref-type="table"}).

The multivariate analysis to investigate the possible influence of other factors on survival is shown in Table [5](#T5){ref-type="table"}. Only the CCI score showed significant influence on long-term survival.

###### 

Five-year survival multivariable analysis

  **Variables**    ***P* value**   **HR (95%CI)**
  ---------------- --------------- ----------------------
  BAR              0.101           0.922 (0.797-1.016)
  Charlson index   0.58            0.764 (0.463-1.007)
  CCI              \< 0.001        0.941 (0.922-0.96)
  HPC              0.311           0.277 ( 0.028-1.402)

BAR: Balance of risk; CCI: Comprehensive complication index; HPC: Hematopoietic progenitor cell.

DISCUSSION
==========

Postoperative complications are frequent and often severe after liver transplantation. Many of them lead to intervention, reoperation, retransplantation and even death\[[@B15]\]. The postoperative mortality of the present study was 7.9%, similar to other European series -8-20%-\[[@B16],[@B17]\] and according to the standard of the Spanish Society of LT\[[@B18]\].

Several studies have investigated the possible influence of complications on long-term survival in other abdominal surgical diseases. In colorectal cancer liver metastases, researchers have hypothesized\[[@B19],[@B20]\] that postoperative morbidity prolongs systemic inflammatory response and induces changes that worsen long-term survival as observed in some studies\[[@B21],[@B22]\].

Gastric cancer investigations\[[@B5],[@B6]\] have also observed association between postoperative complications and lower cancer-specific survival. The authors hypothesize that complications could inhibit immune response to spreading tumor cells leading to decreased survival.

Studies in colorectal cancer\[[@B7]\] have found an association between postoperative morbidity due to exclusively infectious complications --mainly severe - and lower long-term survival.

The same association has been found with esophageal squamous cell carcinoma, especially with pulmonary complications and anastomotic leaks\[[@B9]\].

However, there is no data concerning LT with the exception of papers dealing with graft damage after biliary or ischemic complications\[[@B10]\].

In this study, LT patients with more postoperative complications --estimated by the CCI score -- exhibit a significantly lower survival than patients with fewer complications. No single complication was associated with worse long-term survival, although this could be due to the sample size. Nevertheless, the CCI -- as a measure of overall morbidity -- was shown to be an independent negative predictive factor of long-term survival.

The multivariable analysis was performed to rule out the influence of other variables on long-term survival. MELD was not included because it was already weighted within the BAR variable. Patients with greater preoperative comorbidity could be expected to suffer more complications after surgery, and therefore to have lower long-term survival. However, we found long-term survival was not influenced by other pre-transplant factors such as the Charlson and BAR scores or the presence of hepatocellular carcinoma. Only the CCI score showed significant influence on long-term survival.

Of note, according to the analysed cut-offs, not many complications are needed to enter in the high-risk zone: Only one complication requiring interventional treatment under general anesthesia or two treated without general anesthesia are enough. As a result, enhancing postoperative care is extremely important not only to minimize postoperative mortality but also to improve long-term survival.

The association between complications and poorer survival is not clear. Many of the delayed deaths were related with surgical aspects such as vascular or biliary problems\[[@B23]\], but they seemed more aggressive in those patients with complications in the immediate postoperative period. The main hypothesis is that an increased and prolonged inflammatory systemic response produces deleterious effects. In addition, these patients receive high doses of immunosuppressive drugs in the immediate postoperative period and prolonged treatment thereafter. The role of this treatment is unknown.

This study has several limitations, such as its retrospective and unicentric design, the relatively small number of patients and the limited follow-up of the patients. Prospective multicentric studies with more patients are needed to validate our results.

In conclusion, according to our results, a complicated postoperative period --well defined by means of the CCI score- can influence not only short-term survival, but also long-term survival in LT recipients.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

In surgical procedures such as gastrectomy, esophagectomy or resection of liver metastases, postoperative complications are associated with poorer long-term survival. It is possible this happens in liver transplant (LT) but there are not enough data to establish this relationship.

Research motivation
-------------------

To define whether long-term prognosis is influenced by postoperative complications after LT.

Research objectives
-------------------

To analyze the possible influence of postoperative complications on long-term survival and the ability of the comprehensive complication index (CCI) to predict this.

Research methods
----------------

Retrospective study of 164 LT patients. The medical records concerning postoperative complications and long-term survival were analyzed. Univariate and multivariable tests were performed for statistical analysis.

Research results
----------------

A ROC curve of CCI with 5-year survival was built. Survival curves for comparison of patients with CCI cut-off values of 36 and 33.5 showed significant statistical differences, suggesting that patients with more severe complications exhibit worse long-term survival. A multivariate analysis was carried out to analyze the possible influence of CCI, Charlson comorbidity index, BAR and hepatocellular carcinoma on survival. Only the CCI score showed significant influence on long-term survival.

Research conclusions
--------------------

A complicated postoperative period -- well-defined by means of the CCI score -- can influence not only short-term survival, but also long-term survival of LT patients.

Research perspectives
---------------------

Refinement and surgical technique and postoperative care are mandatory to improve short-term result but this also influence long-term survival.
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